(Q38205274)

31 August 2017

Characterization of host immune responses in Ebola virus infections (English)

1 reference

31 August 2017

Orthoebolavirus zairense

0 references

1

Gary Wong

1 reference

31 August 2017

2

Gary P Kobinger

1 reference

31 August 2017

3

Xiangguo Qiu

1 reference

31 August 2017

18 April 2014

1 reference

Expert Review of Clinical Immunology

31 August 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

31 August 2017

10

1 reference

31 August 2017

6

1 reference

31 August 2017

781-790

1 reference

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany

31 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Transmission of Ebola virus from pigs to non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola Reston virus infection of pigs: clinical significance and transmission potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Cutaneous manifestations of filovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Immunopathology of highly virulent pathogens: insights from Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

21 January 2018

Ebola haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

How Ebola virus counters the interferon system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

The role of the Type I interferon response in the resistance of mice to filovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

The secret life of viral entry glycoproteins: moonlighting in immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Differential potential for envelope glycoprotein-mediated steric shielding of host cell surface proteins among filoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

A new Ebola virus nonstructural glycoprotein expressed through RNA editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Apoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Inflammatory responses in Ebola virus-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Cytokine and chemokine expression in humans infected with Sudan Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Role of natural killer cells in innate protection against lethal ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

In vivo natural killer cell activities revealed by natural killer cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Successful topical respiratory tract immunization of primates against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Persistent infection with ebola virus under conditions of partial immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Experimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Immunization for Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Human asymptomatic Ebola infection and strong inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Early immune responses accompanying human asymptomatic Ebola infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Risk factors for Zaire ebolavirus--specific IgG in rural Gabonese populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

ELISA for the detection of antibodies to Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Immunoglobulin G in Ebola outbreak survivors, Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Persistent immune responses after Ebola virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Type I interferon: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Disease modeling for Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2014.908705

10.1586/1744666X.2014.908705

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

24742338